Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1

被引：168

作者：

Debnath, AK ^{[1
]}

Radigan, L ^{[1
]}

Jiang, SB ^{[1
]}

机构：

[1] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1999年 / 42卷 / 17期

关键词：

D O I：

10.1021/jm990154t

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Recent X-ray crystallographic determination of the HIV-1 envelope glycoprotein gp41 core structure opened up a new avenue to discover antiviral agents for chemotherapy of HIV-1 infection and AIDS. We have undertaken a systematic study to search for anti-HIV-1 lead compounds targeted to gp41. Using molecular docking techniques to screen a database of 20 000 organic molecules, we found 16 compounds with the best fit for docking into the hydrophobic cavity within the gp41 core and with maximum possible interactions with the target site. Further testing of these compounds by an enzyme-linked immunosorbent assay and virus inhibition assays discerned two compounds (ADS-J1 and ADS-J2) having inhibitory activity at micromolar concentrations on the formation of the gp41 core structure and on HIV-1 infection. These two compounds will be used as leads to design more effective HIV-1 inhibitors targeted to the HIV-1 gp41 core structure.

引用

页码：3203 / 3209

页数：7

共 54 条

[1] FUCHSIN ACID SELECTIVELY INHIBITS HUMAN IMMUNODEFICIENCY VIRUS (HIV) REPLICATION INVITRO [J].

BABA, M ;

SCHOLS, D ;

PAUWELS, R ;

BALZARINI, J ;

DECLERCQ, E .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (03) :1404-1411

[2]

BERGER EA, 1997, AIDS, V11, P3

[3] OLIGOMERIZATION OF THE HYDROPHOBIC HEPTAD REPEAT OF GP41 [J].

BERNSTEIN, HB ;

TUCKER, SP ;

KAR, SR ;

MCPHERSON, SA ;

MCPHERSON, DT ;

DUBAY, JW ;

LEBOWITZ, J ;

COMPANS, RW ;

HUNTER, E .

JOURNAL OF VIROLOGY, 1995, 69 (05) :2745-2750

[4] IDENTIFYING SMALL-MOLECULE LEAD COMPOUNDS - THE SCREENING APPROACH TO DRUG DISCOVERY [J].

BEVAN, P ;

RYDER, H ;

SHAW, A .

TRENDS IN BIOTECHNOLOGY, 1995, 13 (03) :115-121

[5] INHIBITION OF THE FUSION-INDUCING CONFORMATIONAL CHANGE OF INFLUENZA HEMAGGLUTININ BY BENZOQUINONES AND HYDROQUINONES [J].

BODIAN, DL ;

YAMASAKI, RB ;

BUSWELL, RL ;

STEARNS, JF ;

WHITE, JM ;

KUNTZ, ID .

BIOCHEMISTRY, 1993, 32 (12) :2967-2978

[6] Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41 [J].

Caffrey, M ;

Cai, ML ;

Kaufman, J ;

Stahl, SJ ;

Wingfield, PT ;

Covell, DG ;

Gronenborn, AM ;

Clore, GM .

EMBO JOURNAL, 1998, 17 (16) :4572-4584

[7] Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86

[8] Core structure of gp41 from the HIV envelope glycoprotein [J].

Chan, DC ;

Fass, D ;

Berger, JM ;

Kim, PS .

CELL, 1997, 89 (02) :263-273

[9] Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target [J].

Chan, DC ;

Chutkowski, CT ;

Kim, PS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15613-15617

[10] HIV entry and its inhibition [J].

Chan, DC ;

Kim, PS .

CELL, 1998, 93 (05) :681-684

← 1 2 3 4 5 6 →